These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9737514)

  • 1. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study.
    Brignole M; Menozzi C; Gianfranchi L; Musso G; Mureddu R; Bottoni N; Lolli G
    Circulation; 1998 Sep; 98(10):953-60. PubMed ID: 9737514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study.
    Brignole M; Gianfranchi L; Menozzi C; Alboni P; Musso G; Bongiorni MG; Gasparini M; Raviele A; Lolli G; Paparella N; Acquarone S
    Circulation; 1997 Oct; 96(8):2617-24. PubMed ID: 9355902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: effect on quality of life and exercise performance.
    Natale A; Zimerman L; Tomassoni G; Newby K; Leonelli F; Fanelli R; Beheiry S; Pisano E
    Pacing Clin Electrophysiol; 1999 Nov; 22(11):1634-9. PubMed ID: 10598967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias.
    Manolis AG; Katsivas AG; Lazaris EE; Vassilopoulos CV; Louvros NE
    J Interv Card Electrophysiol; 1998 Mar; 2(1):71-6. PubMed ID: 9869999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of outcome after radiofrequency catheter ablation of the atrioventricular node for atrial fibrillation and congestive heart failure.
    Twidale N; Manda V; Nave K; Seal A
    Am Heart J; 1998 Oct; 136(4 Pt 1):647-57. PubMed ID: 9778068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological versus invasive treatment in patients with atrial fibrillation].
    Pytkowski M; Jankowska A; Kraska A; Sterliński M; Kowalik I; Krzyzanowski W; Szwed H
    Pol Arch Med Wewn; 2004 Jun; 111(6):703-7. PubMed ID: 15508793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of His-Purkinje Conduction System Pacing with Atrial-Ventricular Node Ablation and Pharmacotherapy in HFpEF Patients with Recurrent Persistent Atrial Fibrillation (HPP-AF study).
    Zhang JF; Pan YW; Li J; Kong XG; Wang M; Xue ZM; Gao J; Fu GS
    Cardiovasc Drugs Ther; 2024 Aug; 38(4):847-858. PubMed ID: 36749453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.
    Kay GN; Ellenbogen KA; Giudici M; Redfield MM; Jenkins LS; Mianulli M; Wilkoff B
    J Interv Card Electrophysiol; 1998 Jun; 2(2):121-35. PubMed ID: 9870004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation.
    Ozcan C; Jahangir A; Friedman PA; Patel PJ; Munger TM; Rea RF; Lloyd MA; Packer DL; Hodge DO; Gersh BJ; Hammill SC; Shen WK
    N Engl J Med; 2001 Apr; 344(14):1043-51. PubMed ID: 11287974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of radiofrequency (RF) ablation of the atrioventricular junction in atrial fibrillation on left ventricular systolic function, exercise tolerance and quality of life].
    Lelakowski J; Majewski J; Bigaj J; Szczepkowski J; Dreher A; Bednarek J
    Przegl Lek; 2009; 66(5):222-7. PubMed ID: 19739578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation. The PAF study. Paroxysmal Atrial Fibrillation.
    Brignole M; Gianfranchi L; Menozzi C; Alboni P; Musso G; Bongiorni MG; Gasparini M; Raviele A; Lolli G; Paparella N; Acquarone S
    Europace; 1999 Jan; 1(1):15-9. PubMed ID: 11220531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term follow-up after catheter-ablation of atrioventricular junction and pacemaker implantation in patients with uncontrolled atrial fibrillation and heart failure].
    Mujović N; Grujić M; Mrdja S; Kocijančić A; Milašinović G; Jovanović V; Čalović Ž; Pavlović S; Stojanov P; Raspopović S; Mujović N; Vujisić-Tešić B; Petrović M; Petrović O
    Srp Arh Celok Lek; 2011; 139(9-10):591-8. PubMed ID: 22069992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation.
    Davie A; McMurray J
    Circulation; 1999 Jun; 99(22):2966; author reply 2966-7. PubMed ID: 10359745
    [No Abstract]   [Full Text] [Related]  

  • 15. [Left ventricular systolic function, paced QT dispersion, exercise tolerance and quality of life in long term follow up after ventricular pacemaker implantation (VVIR) and radiofrequency atrioventricular junction ablation in drug refractory atrial fibrillation].
    Lelakowski J; Małecka B; Bednarek J; Bigaj J
    Pol Merkur Lekarski; 2008 Mar; 24(141):190-4. PubMed ID: 18634282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pacemaker dependence in patients on ablate and pace therapy for atrial fibrillation.
    Occhetta E; Bortnik M; Dell'era G; Zardo F; Dametto E; Sassone B; Gabrieli L; Marino P
    Europace; 2007 Dec; 9(12):1119-23. PubMed ID: 17959682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic improvement after AV nodal ablation and pacemaker implantation for refractory atrial fibrillation and atrial flutter.
    Kim SG; Sompalli V; Rameneni A; Gadde MK; Pamidi M; Pathapati R; Ferrick KJ; Gross J; Ben-Zur U; Furman S; Fisher JD
    Angiology; 1997 Nov; 48(11):933-8. PubMed ID: 9373044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation and congestive heart failure: the intersection of two common diseases.
    Scheinman MM
    Circulation; 1998 Sep; 98(10):941-2. PubMed ID: 9737511
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiofrequency ablation of atrioventricular junction and pacemaker implantation versus modulation of atrioventricular conduction in drug refractory atrial fibrillation.
    Proclemer A; Della Bella P; Tondo C; Facchin D; Carbucicchio C; Riva S; Fioretti P
    Am J Cardiol; 1999 May; 83(10):1437-42. PubMed ID: 10335758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate control in atrial fibrillation.
    Van Gelder IC; Rienstra M; Crijns HJ; Olshansky B
    Lancet; 2016 Aug; 388(10046):818-28. PubMed ID: 27560277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.